Benefits Beyond Weight Loss: Metabolic and Cardiovascular Health Cardiovascular risk reduction semaglutide reduced major cardiovascular events by 20% in the SELECT trial Blood sugar control significant HbA1c reductions in patients with type 2 diabetes or prediabetes Reduced liver fat growing evidence supports GLP-1 therapy for NAFLD and MASLD Sleep apnea improvement tirzepatide demonstrated 63% reduction in apnea-hypopnea index (2024 NEJM trial) Fatty Liver Disease & GLP-1 Therapy Patients with NAFLD/MASLD may see significant improvement with GLP-1 treatment
We proudly serve patients throughout Roanoke and Christiansburg and nearby communities, including: South Roanoke and the Colonial Avenue corridor
Semaglutide targets one receptor, GLP-1
Semaglutide, GLP-1 Drugs, and IBS: Managing Side Effects and Gut Health Aleks Jagiello BSc, MSc, RD Sep 11, 2025 17 min read Glucagon-like peptide-1 (GLP-1) receptor agonist medications, such as semaglutide (brand names Wegovy, Ozempic ), have surged in popularity for weight loss and type 2 diabetes management
Every cell makes its own glutathione, with the liver producing the most
doi: 10.1186/s12967-025-06927-z 30